244 related articles for article (PubMed ID: 30772094)
1. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.
Lee AYS; Körner H
Immunobiology; 2019 May; 224(3):449-454. PubMed ID: 30772094
[TBL] [Abstract][Full Text] [Related]
2. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
Comerford I; Bunting M; Fenix K; Haylock-Jacobs S; Litchfield W; Harata-Lee Y; Turvey M; Brazzatti J; Gregor C; Nguyen P; Kara E; McColl SR
Bioessays; 2010 Dec; 32(12):1067-76. PubMed ID: 20954179
[TBL] [Abstract][Full Text] [Related]
3. CC chemokine receptor 6 (CCR6) in the pathogenesis of systemic lupus erythematosus.
Lee AY; Körner H
Immunol Cell Biol; 2020 Nov; 98(10):845-853. PubMed ID: 32634857
[TBL] [Abstract][Full Text] [Related]
4. In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma.
Ohtani H; Nakayama T; Yoshie O
Pathol Int; 2011 Nov; 61(11):645-51. PubMed ID: 22029675
[TBL] [Abstract][Full Text] [Related]
5. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
Lee AY; Phan TK; Hulett MD; Körner H
Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
[TBL] [Abstract][Full Text] [Related]
6. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
7. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis.
Williams IR
Ann N Y Acad Sci; 2006 Aug; 1072():52-61. PubMed ID: 17057190
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived CCL20 affects B16 melanoma growth in mice.
Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
[TBL] [Abstract][Full Text] [Related]
9. The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
[TBL] [Abstract][Full Text] [Related]
10. STAT5A Modulates Chemokine Receptor CCR6 Expression and Enhances Pre-B Cell Growth in a CCL20-Dependent Manner.
Tsuruyama T; Hiratsuka T; Aini W; Nakamura T
J Cell Biochem; 2016 Nov; 117(11):2630-42. PubMed ID: 27018255
[TBL] [Abstract][Full Text] [Related]
11. A TNF-α-CCL20-CCR6 axis regulates Nod1-induced B cell responses.
Paradis M; Mindt BC; Duerr CU; Rojas OL; Ng D; Boulianne B; McCarthy DD; Yu MD; Summers deLuca LE; Ward LA; Waldron JB; Philpott DJ; Gommerman JL; Fritz JH
J Immunol; 2014 Mar; 192(6):2787-99. PubMed ID: 24534531
[TBL] [Abstract][Full Text] [Related]
12. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
Ghadjar P; Rubie C; Aebersold DM; Keilholz U
Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
[TBL] [Abstract][Full Text] [Related]
13. The CCL20 and CCR6 axis in psoriasis.
Furue K; Ito T; Tsuji G; Nakahara T; Furue M
Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
[TBL] [Abstract][Full Text] [Related]
14. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.
Meitei HT; Jadhav N; Lal G
Autoimmun Rev; 2021 Jul; 20(7):102846. PubMed ID: 33971346
[TBL] [Abstract][Full Text] [Related]
15. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
16. Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases.
Martina MG; Giorgio C; Allodi M; Palese S; Barocelli E; Ballabeni V; Szpakowska M; Chevigné A; Piet van Hamburg J; Davelaar N; Lubberts E; Bertoni S; Radi M
Eur J Med Chem; 2022 Dec; 243():114703. PubMed ID: 36067700
[TBL] [Abstract][Full Text] [Related]
17. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.
Getschman AE; Imai Y; Larsen O; Peterson FC; Wu X; Rosenkilde MM; Hwang ST; Volkman BF
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12460-12465. PubMed ID: 29109267
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.
Hammerich L; Bangen JM; Govaere O; Zimmermann HW; Gassler N; Huss S; Liedtke C; Prinz I; Lira SA; Luedde T; Roskams T; Trautwein C; Heymann F; Tacke F
Hepatology; 2014 Feb; 59(2):630-42. PubMed ID: 23959575
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
[TBL] [Abstract][Full Text] [Related]
20. CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation.
Kulkarni N; Meitei HT; Sonar SA; Sharma PK; Mujeeb VR; Srivastava S; Boppana R; Lal G
J Autoimmun; 2018 Mar; 88():121-130. PubMed ID: 29126851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
